metroweekly.com
74%
329
Monthly PrEP pill shows “potent” results in trials
Healio reports.PrEP, or pre-exposure prophylaxis, uses antiretroviral treatments for HIV to prevent an HIV-negative person from contracting the virus.The most widely known form of PrEP is currently the once-per-day pill known as Truvada, manufactured by Gilead Sciences.But that daily regimen could be transformed into just 12 pills per year if Merck’s trials continue to demonstrate the efficacy of islatravir.Sharon L.
